table of content
Table of Contents
Post-pandemic Era-Global Cholera Vaccines Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Dukoral -Product Introduction and Major Company
1.1.2 Shanchol -Product Introduction and Major Company
1.1.3 Vaxchora -Product Introduction and Major Company
1.1.4 Others -Product Introduction and Major Company
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Five-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Sales (2018 & 2022 & 2026)
2.2 Regional Market Share in Terms of Revenue (2018 & 2022 & 2026)
2.3 Regional Market Share in Terms of Consumption (2018 & 2022 & 2026)
3 Global Cholera Vaccines Market Assessment by Type
3.1 Global Cholera Vaccines Sales by Type (2018-2028)
3.2 Global Cholera Vaccines Revenue by Type (2018-2028)
3.3 North America Cholera Vaccines Sales and Revenue by Type (2018-2028)
3.4 Asia Cholera Vaccines Sales and Revenue by Type (2018-2028)
3.5 Europe Cholera Vaccines Sales and Revenue by Type (2018-2028)
3.6 Middle East & Africa Cholera Vaccines Sales and Revenue by Type (2018-2028)
3.7 South America Cholera Vaccines Sales and Revenue by Type (2018-2028)
4 Historical & Forecast Global Cholera Vaccines Market Assessment by Application
4.1 Global Cholera Vaccines Consumption and Consumption in Different Application Field (2018-2028)
4.2 North America Cholera Vaccines Consumption and Consumption in Different Application Field (2018-2028)
4.3 Asia Cholera Vaccines Consumption and Consumption in Different Application Field (2018-2028)
4.4 Europe Cholera Vaccines Consumption and Consumption in Different Application Field (2018-2028)
4.5 Middle East & Africa Cholera Vaccines Consumption and Consumption in Different Application Field (2018-2028)
4.6 South America Cholera Vaccines Consumption and Consumption in Different Application Field (2018-2028)
5 North America
5.1 US Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
5.2 Canada Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
5.3 Mexico Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
6 Asia
6.1 China Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
6.2 Japan Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
6.3 India Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
6.4 Korea Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
6.5 Southeat Asia Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
7 Europe
7.1 Germany Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
7.2 UK Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
7.3 France Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
7.4 Russia Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
7.5 Italy Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
8 Middle East and Africa
8.1 Saudi Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
8.2 UAE Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
8.3 Egypt Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
8.4 Nigeria Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
8.5 South Africa Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
9 South America
9.1 Brazil Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
9.2 Argentina Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
9.3 Colombia Cholera Vaccines Sales, Revenue and Growth Rate (2018-2028)
10 Global Cholera Vaccines Average Price Trend
10.1 Market Price for Each Type of Cholera Vaccines in North America (2018-2028)
10.2 Market Price for Each Type of Cholera Vaccines in Asia (2018-2028)
10.3 Market Price for Each Type of Cholera Vaccines in Europe (2018-2028)
10.4 Market Price for Each Type of Cholera Vaccines in Middle East & Africa (2018-2028)
10.5 Market Price for Each Type of Cholera Vaccines in South America (2018-2028)
11 Value Chain
11.1 Cholera Vaccines Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Cholera Vaccines Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.2.2 Post-pandemic Era
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Major Players of Global Cholera Vaccines Market, Competitive Analysis
12.1 Shantha Biotechnics Private Limited
12.1.1 Shantha Biotechnics Private Limited Company Profiles and Company News
12.1.2 Shantha Biotechnics Private Limited Product Introduction
12.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Sales, Revenue (2018-2022)
12.1.4 SWOT Analysis
12.2 PaxVax, Inc.
12.2.1 PaxVax, Inc. Company Profiles and Company News
12.2.2 PaxVax, Inc. Product Introduction
12.2.3 PaxVax, Inc. Cholera Vaccines Sales, Revenue (2018-2022)
12.2.4 SWOT Analysis
12.3 Valneva SE
12.3.1 Valneva SE Company Profiles and Company News
12.3.2 Valneva SE Product Introduction
12.3.3 Valneva SE Cholera Vaccines Sales, Revenue (2018-2022)
12.3.4 SWOT Analysis
12.4 Merck and Co., Inc.
12.4.1 Merck and Co., Inc. Company Profiles and Company News
12.4.2 Merck and Co., Inc. Product Introduction
12.4.3 Merck and Co., Inc. Cholera Vaccines Sales, Revenue (2018-2022)
12.4.4 SWOT Analysis
12.5 Mitsubishi Tanabe Pharma Corporation
12.5.1 GlaxoSmithKline plc (GSK) Company Profiles and Company News
12.5.2 GlaxoSmithKline plc (GSK) Product Introduction
12.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Sales, Revenue (2018-2022)
12.5.4 SWOT Analysis
12.6 Astellas Pharma, Inc.
12.6.1 Astellas Pharma, Inc. Company Profiles and Company News
12.6.2 Astellas Pharma, Inc. Product Introduction
12.6.3 Astellas Pharma, Inc. Cholera Vaccines Sales, Revenue (2018-2022)
12.6.4 SWOT Analysis
12.7 Pfizer, Inc.
12.7.1 Pfizer, Inc. Company Profiles and Company News
12.7.2 Pfizer, Inc. Product Introduction
12.7.3 Pfizer, Inc. Cholera Vaccines Sales, Revenue (2018-2022)
12.7.4 SWOT Analysis
12.8 Emergent BioSolutions, Inc.
12.8.1 Emergent BioSolutions, Inc. Company Profiles and Company News
12.8.2 Emergent BioSolutions, Inc. Product Introduction
12.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Sales, Revenue (2018-2022)
12.8.4 SWOT Analysis
12.9 Mitsubishi Tanabe Pharma Corporation
12.9.1 Mitsubishi Tanabe Pharma Corporation Company Profiles and Company News
12.9.2 Mitsubishi Tanabe Pharma Corporation Product Introduction
12.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Sales, Revenue (2018-2022)
12.9.4 SWOT Analysis
12.10 Takeda Pharmaceutical Co., Ltd.
12.10.1 Takeda Pharmaceutical Co., Ltd. Company Profiles and Company News
12.10.2 Takeda Pharmaceutical Co., Ltd. Product Introduction
12.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Sales, Revenue (2018-2022)
12.10.4 SWOT Analysis
13 Global Cholera Vaccines Market, Competitive Landscape and Market Forecast
13.1 Key Companies Dominating the Global Cholera Vaccines Market
13.2 Concentration Ratio (CR5) of Global Cholera Vaccines Market (2018)
13.2.1 Market Share of Top 5 Players in Term of Revenue (2018)
13.3 Concentration Ratio (CR5) of Global Cholera Vaccines Market (2022)
13.3.1 Market Share of Top 5 Players in Term of Revenue (2022)
14 Conclusion
15 Methodology and Data Source
